德維特保健合作公司DVA
紐約證券 · USD
137.79
-2.58
(-1.84%)
盤中 08/02 01:10 (UTC+8)
08/02 01:10 (UTC+8)
德維特保健合作公司DVA
137.79
-2.58
(-1.84%)
財務數據
損益表
- 29.17
- 28.73
- 30.00
- 31.21
- 31.46
- 30.71
- 31.87
- 32.64
- 32.95
- 32.24
- -1.08
- -1.51
- 4.44
- 4.03
- 0.78
- -2.39
- 3.78
- 2.41
- 0.95
- -2.16
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 3,223,529 | 3,294,683 | 3,263,590 | 3,186,722 | 3,070,555 | 3,145,747 | 3,121,332 | 3,000,369 | 2,872,699 | 2,916,888 |
營業成本 | 2,239,660 | 2,225,371 | 2,151,875 | 2,142,299 | 2,078,976 | 2,138,369 | 2,067,315 | 2,055,844 | 2,058,189 | 2,088,681 |
營業毛利 | 983,869 | 1,069,312 | 1,111,715 | 1,044,423 | 991,579 | 1,007,378 | 1,054,017 | 944,525 | 814,510 | 828,207 |
營業費用 | - | - | - | - | - | 622,831 | 565,306 | 547,688 | 509,685 | 573,779 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 374,090 | 414,482 | 393,534 | 367,845 | 362,480 | 401,471 | 376,883 | 364,016 | 331,614 | 379,711 |
非經常性項目費用 | - | - | - | - | - | 26,083 | - | - | - | - |
其他營業費用 | 176,451 | 174,102 | 187,014 | 175,661 | 187,083 | 195,277 | 188,423 | 183,672 | 178,071 | 194,068 |
營業利益 | 438,937 | 565,362 | 534,878 | 506,398 | 483,845 | 389,909 | 495,939 | 405,291 | 311,645 | 256,252 |
其他收入及費用 | -152,604 | -77,310 | -161,444 | -134,958 | -76,912 | -100,842 | -117,730 | -110,096 | -97,022 | -108,759 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 286,333 | 413,733 | 373,434 | 371,440 | 371,786 | 289,067 | 378,209 | 295,195 | 214,623 | 147,493 |
所得稅 | 54,117 | 64,488 | 77,674 | 71,688 | 65,806 | 58,495 | 68,848 | 48,818 | 43,955 | 34,330 |
稅後純益 | 162,917 | 259,329 | 214,688 | 222,676 | 239,649 | 150,665 | 246,632 | 178,691 | 115,547 | 68,103 |
基本每股稅後盈餘(元) | 2.05 | 3.18 | 2.56 | 2.56 | 2.73 | 1.67 | 2.70 | 1.96 | 1.28 | 0.76 |
稀釋每股稅後盈餘(元) | 2.00 | 3.07 | 2.51 | 2.50 | 2.65 | 1.62 | 2.63 | 1.92 | 1.25 | 0.78 |
基本平均股數(千股) | 79368.00 | 81620.00 | 83721.00 | 86899.00 | 87775.00 | 90353.00 | 91322.00 | 90984.00 | 90497.00 | 90122.00 |
稀釋平均股數(千股) | 81275.00 | 83854.00 | 85795.00 | 88950.00 | 90547.00 | 92782.00 | 94041.00 | 93418.00 | 92483.00 | 91910.00 |
還原基本每股稅後盈餘(元) | 2.05 | 3.18 | 2.56 | 2.56 | 2.73 | 1.67 | 2.70 | 1.96 | 1.28 | 0.76 |
還原稀釋每股稅後盈餘(元) | 2.00 | 3.07 | 2.51 | 2.50 | 2.65 | 1.62 | 2.63 | 1.92 | 1.25 | 0.78 |
還原基本平均股數(千股) | 79,368 | 81,620 | 83,721 | 86,899 | 87,775 | 90,353 | 91,322 | 90,984 | 90,497 | 90,122 |
還原稀釋平均股數(千股) | 81,275 | 83,854 | 85,795 | 88,950 | 90,547 | 92,782 | 94,041 | 93,418 | 92,483 | 91,910 |
EBITDA(千元) | 393,485 | 497,919 | 479,376 | 470,025 | 492,538 | 404,437 | 503,903 | 411,181 | 337,573 | 296,501 |